Skip to main content

Table 2 Therapeutic effect after balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma

From: Hemodynamic changes under balloon occlusion of hepatic artery: predictor of the short-term therapeutic effect of balloon-occluded transcatheter arterial chemolipiodolization using miriplatin for hepatocellular carcinoma

  Therapeutic effect p value
Poor (TE1/2) Good (TE3/4)
Age
 Mean ± SD 73.1 ± 2.1 70.1 ± 2.5 0.366
Sex
 Male 16 11 0.700
 Female 4 4
Child–Pugh class
 A 17 11 0.430
 B 3 4
 C 0 0
AFP (ng/mL)
 <20 12 10 0.928
 ≥20 8 5
DCP (mAU/mL)
 <40 8 9 0.315
 ≥40 12 6
History of previous TACE
 Yes 13 11 0.721
 No 7 4
Tumor location
 S1 or S4 6 2 0.419
 Others 14 13
Level of balloon occlusion:
 Peripheral/subsegmental 10 13 0.034
 Segmental/lobar 10 2
CTHA finding
 Group A 5 5 0.003
 Group B 2 8
 Group C 13 2
CT value after B-TACE (HU) 711.8 ± 74.2 958.5 ± 85.7 0.037
  1. AFP alpha-fetoprotein, DCP des-gamma-carboxyprothrombin